E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

  • Law Blogs

Become a Fan

« USPTO and EPO to Develop Joint Patent Classification System | Main | Pfizer and Biocon Sign Global Commercialization Agreement on Biosimilars »

October 27, 2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451ca1469e20133f55f2136970b

Listed below are links to weblogs that reference Appellees File Reply Brief in Therasense v. Becton Dickinson:

Comments

In a recent interview with patent law expert Gene Quinn, Chief Judge Michel stated that "the Federal Circuit needs to clean up its act on inequitable conduct," and expressed hope that Therasense will make progress in that regard. I certainly hope so. The abuse of this part of patent law needs to be curtailed.
http://www.GeneralPatent.com

The comments to this entry are closed.

December 2014

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31